ZA997638B - Treatment of papillomavirus infections. - Google Patents
Treatment of papillomavirus infections.Info
- Publication number
- ZA997638B ZA997638B ZA9907638A ZA997638A ZA997638B ZA 997638 B ZA997638 B ZA 997638B ZA 9907638 A ZA9907638 A ZA 9907638A ZA 997638 A ZA997638 A ZA 997638A ZA 997638 B ZA997638 B ZA 997638B
- Authority
- ZA
- South Africa
- Prior art keywords
- treatment
- infection
- vlps
- papillomavirus infections
- papillomavirus
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7024—Esters of saccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/736—Glucomannans or galactomannans, e.g. locust bean gum, guar gum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20023—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Oncology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPP7653A AUPP765398A0 (en) | 1998-12-11 | 1998-12-11 | Treatment of papillomavirus infections |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA997638B true ZA997638B (en) | 2000-07-06 |
Family
ID=3811858
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA9907638A ZA997638B (en) | 1998-12-11 | 1999-12-13 | Treatment of papillomavirus infections. |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US6867033B1 (xx) |
| EP (1) | EP1144005B1 (xx) |
| JP (2) | JP5274737B2 (xx) |
| KR (1) | KR100617485B1 (xx) |
| AT (1) | ATE344053T1 (xx) |
| AU (1) | AUPP765398A0 (xx) |
| CA (1) | CA2353866C (xx) |
| DE (1) | DE69933891T2 (xx) |
| DK (1) | DK1144005T3 (xx) |
| NZ (1) | NZ512850A (xx) |
| WO (1) | WO2000035478A1 (xx) |
| ZA (1) | ZA997638B (xx) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003519084A (ja) * | 1998-10-16 | 2003-06-17 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | ワクチン |
| AUPP765398A0 (en) | 1998-12-11 | 1999-01-14 | University Of Queensland, The | Treatment of papillomavirus infections |
| FR2802426B1 (fr) * | 1999-12-15 | 2004-04-02 | Neovacs | Utilisation de proteines immunogenes immunosuppressives et/ou angiogeniques rendues inactives, pour la production d'iga secretoires |
| AUPR446801A0 (en) | 2001-04-18 | 2001-05-17 | University Of Queensland, The | Novel compositions and uses therefor |
| EP1422526A1 (en) * | 2002-10-28 | 2004-05-26 | MTM Laboratories AG | Method for improved diagnosis of dysplasias |
| WO2006113209A1 (en) | 2005-04-15 | 2006-10-26 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods and compositions for producing an enhanced immune response to a human papillomavirus immunogen |
| EP3385274B1 (en) * | 2015-12-04 | 2021-09-22 | Xiamen University | Mutant of human papillomavirus type 11 l1 protein |
| WO2023196884A1 (en) | 2022-04-06 | 2023-10-12 | Juno Therapeutics, Inc. | Detection assay for human papillomavirus (hpv) type 16 (hpv-16) |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1359156T3 (da) | 1991-07-19 | 2007-04-10 | Univ Queensland | Vaccine mod humanpapillomavirus |
| US5437951A (en) | 1992-09-03 | 1995-08-01 | The United States Of America As Represented By The Department Of Health And Human Services | Self-assembling recombinant papillomavirus capsid proteins |
| JP3863559B2 (ja) * | 1994-05-16 | 2006-12-27 | メルク エンド カンパニー インコーポレーテッド | 乳頭腫ウィルスワクチン |
| US5888516A (en) * | 1994-05-16 | 1999-03-30 | Merck & Co. Inc. | Recombinant papillomavirus vaccines |
| AU3342195A (en) * | 1994-09-06 | 1996-03-27 | Scan-Web I/S | A method and a system for manufacturing broad airlaid paper webs containing an absorbing powder |
| AR004464A1 (es) * | 1994-11-14 | 1998-12-16 | Merck Sharp & Dohme | Un metodo para producir una proteina de capside de papilomavirus |
| IL117459A (en) | 1995-03-22 | 2005-11-20 | Merck & Co Inc | Dna encoding human papillomavirus type 18 |
| IL117591A0 (en) | 1995-03-30 | 1996-07-23 | Merck & Co Inc | Synthetic DNA encoding human papillomavirus type 11 L1 protein |
| US5821087A (en) * | 1995-03-30 | 1998-10-13 | Merck & Co., Inc. | Production of recombinant human papillomavirus type II protein utilizing papillomavirus 6/11 hybrid DNA |
| WO1998010790A1 (en) * | 1996-09-11 | 1998-03-19 | Merck & Co., Inc. | Papillomavirus vaccine formulation |
| GB9621091D0 (en) | 1996-10-09 | 1996-11-27 | Fondation Pour Le Perfectionem | Attenuated microorganisms strains and their uses |
| CA2275259C (en) * | 1996-12-20 | 2008-02-12 | Merck & Co., Inc. | Formulations of recombinant papillomavirus vaccines |
| DE69822452T2 (de) | 1997-04-08 | 2006-04-20 | Merck & Co., Inc. | Stabilisierte humane papillomaviruszusammensetzungen |
| DE19735118C1 (de) * | 1997-08-13 | 1998-08-13 | Deutsches Krebsforsch | Papillomviren, Mittel zu deren Nachweis sowie zur Therapie von durch sie verursachten Erkrankungen |
| US6228368B1 (en) * | 1997-10-06 | 2001-05-08 | Loyola University Of Chicago | Papilloma virus capsomere formulations and method of use |
| AUPP765398A0 (en) | 1998-12-11 | 1999-01-14 | University Of Queensland, The | Treatment of papillomavirus infections |
| US6436402B1 (en) * | 1999-10-15 | 2002-08-20 | Merck & Co., Inc. | Process for making human papillomavirus virus-like particles with improved properties |
-
1998
- 1998-12-11 AU AUPP7653A patent/AUPP765398A0/en not_active Abandoned
-
1999
- 1999-12-13 DE DE69933891T patent/DE69933891T2/de not_active Expired - Lifetime
- 1999-12-13 US US09/868,009 patent/US6867033B1/en not_active Expired - Lifetime
- 1999-12-13 WO PCT/AU1999/001108 patent/WO2000035478A1/en active IP Right Grant
- 1999-12-13 DK DK99966765T patent/DK1144005T3/da active
- 1999-12-13 AT AT99966765T patent/ATE344053T1/de active
- 1999-12-13 ZA ZA9907638A patent/ZA997638B/xx unknown
- 1999-12-13 NZ NZ512850A patent/NZ512850A/xx not_active IP Right Cessation
- 1999-12-13 KR KR1020017007244A patent/KR100617485B1/ko active IP Right Grant
- 1999-12-13 CA CA2353866A patent/CA2353866C/en not_active Expired - Lifetime
- 1999-12-13 JP JP2000587797A patent/JP5274737B2/ja not_active Expired - Lifetime
- 1999-12-13 EP EP99966765A patent/EP1144005B1/en not_active Expired - Lifetime
-
2005
- 2005-03-15 US US11/079,525 patent/US7172870B2/en not_active Expired - Lifetime
-
2010
- 2010-11-25 JP JP2010261979A patent/JP2011037902A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| DE69933891D1 (de) | 2006-12-14 |
| EP1144005B1 (en) | 2006-11-02 |
| DK1144005T3 (da) | 2007-03-05 |
| JP5274737B2 (ja) | 2013-08-28 |
| JP2002532434A (ja) | 2002-10-02 |
| KR20010103711A (ko) | 2001-11-23 |
| NZ512850A (en) | 2004-01-30 |
| CA2353866C (en) | 2013-11-19 |
| EP1144005A1 (en) | 2001-10-17 |
| US20050244433A1 (en) | 2005-11-03 |
| CA2353866A1 (en) | 2000-06-22 |
| EP1144005A4 (en) | 2005-02-09 |
| ATE344053T1 (de) | 2006-11-15 |
| US6867033B1 (en) | 2005-03-15 |
| JP2011037902A (ja) | 2011-02-24 |
| US7172870B2 (en) | 2007-02-06 |
| DE69933891T2 (de) | 2007-06-21 |
| KR100617485B1 (ko) | 2006-09-01 |
| AUPP765398A0 (en) | 1999-01-14 |
| WO2000035478A1 (en) | 2000-06-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60119734D1 (de) | Hpv-e7 zur behandlung von menschlichem papillomavirus | |
| AU2002360592A1 (en) | Inhibitors of hepatitis c virus | |
| EP1189621A4 (en) | UNFERMENTED GEL FRACTION OF PSYLLIUM SEED COVERS | |
| LU91314I2 (fr) | "Combinaison de particules viroides de papillomavirus humain de type 6, 11, 16 et 18 (GARDASIL -GilGARD )" | |
| EP1273298A3 (en) | Ritonavir in combination with an additional HIV protease inhibitor for treating aids | |
| BR9814606A (pt) | Formulação de vacina e métodos de tratamento de um indivìduo infectado com um vìrus hpv e de prevenção de infecção por papiloma vìrus | |
| AU3475097A (en) | Substituted cyclopentane compounds useful as neuraminidase inhibitors | |
| AU2001234521A1 (en) | Methods of using a beverage composition | |
| AU2001235006A1 (en) | Prophylactic and therapeutic monoclonal antibodies | |
| ZA997638B (en) | Treatment of papillomavirus infections. | |
| ATE402257T1 (de) | Antisense gegen c-myc zur behandlung von polyzystischer nierenkrankheit | |
| AU2002219881A1 (en) | Methods and compositions for the treatment of human immunodeficiency virus infection | |
| AU4149699A (en) | Use of inactivated immunosuppressive and/or angiogenic immunogenic proteins, preparation method and pharmaceutical or vaccine uses | |
| NO20043112L (no) | Peptider egnet for behandling av human papillomavirus (HPV)-assosiert kreft og andre epiteliale tumorer | |
| FR2725990B1 (fr) | Derives hydrosolubles d'epipodophyllotoxine, leur procede de preparation, leur utilisation a titre de medicament, et leur utilisation destinee aux traitements anticancereux | |
| AU3308099A (en) | Method for the treatment of pain, including chronic and female specific pain | |
| AUPP870999A0 (en) | Method of treatment of equine disease | |
| MA26648A1 (fr) | Associations thérapeutiques pour le traitement de maladies osseuses, et procédé pour leur préparation. | |
| AU4034800A (en) | Novel compositions and methods for prevention and treatment of protozoal disease | |
| DK0680333T3 (da) | Forebyggelse og behandling af cytomegalovirus ved hjælp af aminopeptidase | |
| SU1503804A1 (ru) | Способ мирингопластики | |
| AU2120502A (en) | Orally ingestible preparation of mistletoe lectins and method | |
| AU3593095A (en) | Method of treatment of human immunodeficiency virus (hiv) infection | |
| UA31350A (uk) | Спосіб екстрації сублюксован0го кришталика | |
| WO1997006770A3 (en) | Chitin extract for treatment of skin disease |